Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arteris, Inc. - Common Stock (NQ:AIP)

14.59 +1.19 (+8.88%)
Streaming Delayed Price Updated: 10:44 AM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Arteris, Inc. - Common Stock

< Previous 1 2 3 Next >
Is The Freeway In Sight?
Elon Musk said that Tesla’s future lies in two innovations: autonomous vehicles, and autonomous humanoid robots. While the robots could be huge, they are still years away. What I’m interested in are... 
Via Talk Markets
Topics Stocks / Equities
What to Expect from Arteris's Earnings
 
Via Benzinga
A Glimpse Into The Expert Outlook On Arteris Through 4 Analysts
 
Via Benzinga
AIP Stock Earnings: Arteris Beats EPS, Beats Revenue for Q2 2024
AIP stock results show that Arteris beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Information Technology Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
12 Information Technology Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Recap: Arteris Q4 Earnings
 
Via Benzinga
Arteris's Earnings: A Preview
 
Via Benzinga
Analyst Expectations for Arteris's Future
 
Via Benzinga
12 Information Technology Stocks Moving In Friday's Intraday Session
 
Via Benzinga
AIP Stock Earnings: Arteris Beats EPS, Beats Revenue for Q1 2024
AIP stock results show that Arteris beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
7 Millionaire-Maker Tech Stocks to Buy Before They Quadruple
Look beyond the big tech winners. These under-the-radar tech stocks could have explosive return potential in the years ahead. 
Via InvestorPlace
12 Information Technology Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
A Preview Of Arteris's Earnings
 
Via Benzinga
Arteris Earnings Perspective: Return On Capital Employed
 
Via Benzinga
Recap: Arteris Q1 Earnings
 
Via Benzinga
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares climbed 96% to $0.2921 after falling over 7% on Tuesday. 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
TD Cowen Maintains Outperform Rating for Arteris: Here's What You Need To Know
 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
AI Stocks: What Investors Need To Know As The Market Shifts To 'Inferencing'
Amid the boom in AI stocks, the big money is now in training models. That will shift to "inferencing" and running AI apps. 
Via Investor's Business Daily
Topics Artificial Intelligence
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
12 Information Technology Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
12 Information Technology Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
12 Information Technology Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.